You have 9 free searches left this month | for more free features.

Condition

Colorectal Cancer Microsatellite Stable (MSS) (1)

Metastatic Castration Resistant Prostate Cancer (mCRPC) (1)

Non-small Cell Lung Cancer (NSCLC) (1)

Ovarian Cancer (1)

Pancreatic Ductal Adenocarcinoma (PDAC) (1)

Renal Cell Carcinoma (RCC) (1)

Solid Tumors (1)

Triple Negative Breast Cancer (TNBC) (1)

Overall Status

Recruiting (1)

Terminated (1)

Phase

early phase 1 (1)

phase 1 (1)

Sponsor

Novartis Pharmaceuticals (2)

Collaborator

Intervention

nir178 (2)

nzv930 (2)

pdr001 (2)

kaz954 (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

NZV930

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumors Trial in Worldwide (KAZ954, PDR001, NIR178)

Recruiting

Solid Tumors

KAZ954
+3 more

Los Angeles, California
+12 more

Dec 23, 2022

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated

Non-small Cell Lung Cancer (NSCLC)
+6 more

NZV930
+2 more

Tampa, Florida
+9 more

Nov 2, 2022